Literature DB >> 7848644

Multiple metachronous skin squamous cell carcinomas and epidermodysplasia verruciformis in the head region: a human papilloma virus-associated disease.

B P Weber1, G Fierlbeck, H G Kempf.   

Abstract

Data from a young adult man with epidermodysplasia verruciformis (EV) and multiple metachronous spinaliomas in the head and neck region are presented. Diagnosis of this rare, human papilloma virus (HPV)-associated disease was based on: (1) Typical skin lesions, including viral warts, verruca plana-type lesions and pityriasis versicilor; (2) typical histological features, including "foamy giant keratinocytes"; (3) evidence of HPV 5, 8 and 20 in pityriasis versicilor-like lesions; (4) a cellular immunodeficiency due to a relative T-helper-cell deficit. No specific treatment of EV is known, so that therapy concentrates on early removal of spinaliomas and treatment of intercurrent infections. Since EV patients have numerous benign skin lesions and frequently develop metastatic and non-metastatic carcinomas, molecular changes of HPV during carcinogenesis can be studied.

Entities:  

Mesh:

Year:  1994        PMID: 7848644     DOI: 10.1007/bf00171541

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  21 in total

1.  Recombinant interferon-alpha-2C in laryngeal papillomatosis: preliminary results of a prospective multicentre trial.

Authors:  H P Zenner; W Kley; P Clarós; A Clarós; Z Labas; L P Löbe; R Pavelka; P Plath; O Ribari; D Niethammer
Journal:  Oncology       Date:  1985       Impact factor: 2.935

2.  [Demonstration and organizational structure of the DNA of human papillomaviruses in laryngeal and hypopharyngeal carcinomas].

Authors:  A Stremlau; H P Zenner; L Gissmann; H zur Hausen
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1987-06

3.  Application of beta-interferon in virus-induced papillomas.

Authors:  M Niimura
Journal:  J Invest Dermatol       Date:  1990-12       Impact factor: 8.551

4.  Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis.

Authors:  S Majewski; J Malejczyk; S Jablonska; J Misiewicz; L Rudnicka; S Obalek; G Orth
Journal:  J Am Acad Dermatol       Date:  1990-03       Impact factor: 11.527

5.  Human papillomavirus DNA in squamous cell carcinoma of the upper aerodigestive tract.

Authors:  T Ishibashi; S Matsushima; Y Tsunokawa; M Asai; Y Nomura; T Sugimura; M Terada
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-03

6.  [Condylomata acuminata--topical and systemic interferon therapy].

Authors:  G Fierlbeck; H Breuninger; B Fierlbeck; G Rassner
Journal:  Hautarzt       Date:  1991-01       Impact factor: 0.751

7.  Molecular characteristics and physical state of human papillomavirus DNA change with progressing malignancy: studies in a patient with epidermodysplasia verruciformis.

Authors:  Y Yabe; Y Tanimura; A Sakai; T Hitsumoto; N Nohara
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

8.  Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes.

Authors:  M C Deau; M Favre; G Orth
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

9.  Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment.

Authors:  G Gross; K Ellinger; A Roussaki; P G Fuchs; H H Peter; H Pfister
Journal:  J Invest Dermatol       Date:  1988-07       Impact factor: 8.551

10.  X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred.

Authors:  E J Androphy; I Dvoretzky; D R Lowy
Journal:  Arch Dermatol       Date:  1985-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.